ArticleBMC cancer2025

Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer.

Constance Delaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.